Clinical trials are at the heart of medical advances. They are designed to test the safety and efficacy of new approaches to preventing, detecting, and treating disease. Trials also look for new ways to use existing treatments, new drugs, surgical procedures and devices.
Clinical trial participants enroll to possibly receive the newest treatment for their conditions, to have additional care and attention from clinical trials, staff and to help researchers find better treatments for future patients.In the United States, clinical trials must meet rigorous standards and be registered with the National Institutes of Health.
Investigator is a medical doctor that is responsible for protecting the rights, safety, and welfare of patients enrolled in clinical trials. A principal investigator is the lead investigator of a study that is responsible for the conduct and supervision of the entire trial at the site. Investigators at Austin Clinical Research are highly trained, board-certified ophthalmologists, three of which specialize in retina.
Our investigators have extensive clinical trial experience in a variety of eye conditions, including age-related macular degeneration, diabetic eye disease, retinal vein occlusions, uveitis, dry eyes and glaucoma.
My doctors and the entire staff are personable, professional and have changed my life for the better. If you have a chance to join a clinical trial at Austin Clinical Research, do it without hesitation. It is so worth it.
When you participate in a clinical trial, you are contributing to research that could bring new treatments one step closer to reaching patients across the nation. Clinical trials offer cutting-edge treatment options, and participation in a clinical trial is free of charge. For more information about our trials, please visit our enrolling trials page.
Learn More About Enrolling TrialsRetinal diseases vary widely, but most of them cause visual symptoms.
The eye contains millions of light-sensitive cells (rods and cones) and other nerve cells that receive and organize visual information. Your retina sends this information to your brain through your optic nerve, enabling you to see.
Treatment is available for some retinal diseases, but not all. By participating in a clinical trial, you are contributing to development of new and better treatments for the future. We strive to offer innovative treatment options that may be more effective, may slow or halt the disease process, prolong treatment intervals, and improve or maintain your vision.
By participating in the trial, I would receive the proper treatment for my BRVO. I would receive the existing drug which had been administered for BRVO for several years or a new drug which had shown positive results for similar eye problems. In addition, I felt I was participating in medical science throughout the trial.
